133. HBV Vaccination: Waning Immunity, Immunocompromised Hosts, and New Horizons
Session: Symposium: Hepatitis B: Current and Future Challenges in Treatment and Prevention
Thursday, October 4, 2018: 10:55 AM
Room: N 25
Kenneth Sherman, MD, Digestive Diseases, University Cincinnati College of Medicine, Cincinnati, OH

Kenneth E. Sherman, MD, PhD received his BS & PhD from Rutgers University and his MD from George Washington University. He holds an endowed chair as the Gould Professor of Medicine and serves as the Director of the Division of Digestive Diseases at the University of Cincinnati College Of Medicine. Dr. Sherman is the author of over 250 articles, abstracts and book chapters on viral hepatitis. His research focus involves the pathogenesis, evaluation and treatment of liver disease in immunosuppressed patients, including those with HIV. Dr. Sherman has held numerous leadership positions in the field. Currently, he is the elected Chair of the AGA Liver & Biliary section. He also serves on the ACTG Hepatitis TSG Steering Committee.


Disclosures:

K. Sherman, Merck: Grant Investigator and Scientific Advisor , Clinical trial contract , Consulting fee and Research grant . Innovio: Investigator , Clinical trial contract .

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.